Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Altium Capital Management

Latest statistics and disclosures from Altium Capital Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are VERA, XENE, Viking Therapeutics Inc put, Advisorshares Tr call, AXSM, and represent 32.55% of Altium Capital Management's stock portfolio.
Added to shares of these 10 stocks: VERA (+$16M), Viking Therapeutics Inc put (+$14M), Advisorshares Tr call (+$11M), AVDL (+$9.3M), CPRX (+$8.0M), VKTX (+$7.0M), SVRA (+$6.6M), ITCI (+$5.9M), CYBN (+$5.8M), LRMR (+$5.3M).
Started 37 new stock positions in MIST, Rapt Therapeutics, Geron Corp Cmn Stock cmn, CPRX, EVOK, LBPH, MOBXW, Boundless Bio, RCKTW, AZTR.
Reduced shares in these 10 stocks: ATXS (-$17M), Cymabay Therapeutics (-$12M), Immunovant (-$12M), , AMLX (-$9.8M), BHVN (-$8.0M), GPCR (-$7.8M), ADMA (-$7.8M), CRNX (-$7.8M), Karuna Therapeutics Ord (-$5.7M).
Sold out of its positions in ACRS, Aclaris Therapeutics Inc put, ABOS, AMLX, Anavex Life Sciences Corp call, Anavex Life Sciences Corp put, Apellis Pharmaceuticals Inc put, COGT, CRNX, Cymabay Therapeutics.
Altium Capital Management was a net buyer of stock by $16M.
Altium Capital Management has $253M in assets under management (AUM), dropping by 31.78%.
Central Index Key (CIK): 0001746382

Tip: Access up to 7 years of quarterly data

Positions held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Altium Capital Management

Altium Capital Management holds 72 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Vera Therapeutics Cl A (VERA)	12.1	$31M	+112%	710k	43.12	View chart
Xenon Pharmaceuticals (XENE)	5.9	$15M	+52%	348k	43.05	View chart
Viking Therapeutics Put Put Option	5.7	$14M	NEW	175k	82.00	View chart
Advisorshares Tr Call Call Option	4.5	$11M	NEW	1.1M	10.01	View chart
Axsome Therapeutics (AXSM)	4.4	$11M	+50%	138k	79.80	View chart
Adma Biologics (ADMA)	4.0	$10M	-43%	1.5M	6.60	View chart
Alimera Sciences Com New (ALIM)	3.9	$9.9M	-13%	2.6M	3.90	View chart
Avadel Pharmaceuticals Sponsored Adr (AVDL)	3.7	$9.3M	NEW	553k	16.89	View chart
Xtant Med Hldgs Com New (XTNT)	3.5	$8.9M	-14%	7.6M	1.17	View chart
Catalyst Pharmaceutical Partners (CPRX)	3.2	$8.0M	NEW	500k	15.94	View chart
Intra Cellular Therapies (ITCI)	3.1	$7.8M	+303%	113k	69.20	View chart
Biohaven (BHVN)	3.0	$7.7M	-51%	140k	54.69	View chart
Viking Therapeutics (VKTX)	2.8	$7.0M	NEW	85k	82.00	View chart
Olema Pharmaceuticals (OLMA)	2.7	$6.8M	+80%	605k	11.32	View chart
Savara (SVRA)	2.6	$6.6M	NEW	1.3M	4.98	View chart
Soleno Therapeutics (SLNO)	2.6	$6.5M	+224%	153k	42.80	View chart
Cybin Ord (CYBN)	2.3	$5.8M	NEW	14M	0.41	View chart
Oric Pharmaceuticals (ORIC)	2.2	$5.6M	-3%	405k	13.75	View chart
Larimar Therapeutics (LRMR)	2.1	$5.3M	NEW	695k	7.59	View chart
Mirum Pharmaceuticals (MIRM)	2.1	$5.2M	NEW	208k	25.12	View chart
Neurogene (NGNE)	2.0	$5.1M	NEW	100k	50.90	View chart
Praxis Precision Medicines I Com New (PRAX)	1.9	$4.8M	NEW	78k	61.02	View chart
Achieve Life Sciences (ACHV)	1.5	$3.8M	NEW	836k	4.54	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	1.5	$3.8M	NEW	25k	151.17	View chart
Longboard Pharmaceuticals In (LBPH)	1.5	$3.7M	NEW	170k	21.60	View chart
Insmed Com Par $.01 (INSM)	1.3	$3.3M	NEW	120k	27.13	View chart
Realreal (REAL)	1.2	$3.1M	NEW	800k	3.91	View chart
Alpine Immune Sciences (ALPN)	1.2	$3.1M	NEW	78k	39.64	View chart
Boundless Bio	1.1	$2.9M	NEW	200k	14.25	View chart
Aquestive Therapeutics (AQST)	1.1	$2.8M	NEW	665k	4.26	View chart
Rhythm Pharmaceuticals (RYTM)	1.0	$2.5M	NEW	57k	43.33	View chart
Milestone Pharmaceuticals (MIST)	0.9	$2.2M	NEW	1.2M	1.79	View chart
Astria Therapeutics (ATXS)	0.8	$2.0M	-89%	143k	14.07	View chart
Zevra Therapeutics Com New (ZVRA)	0.8	$2.0M	NEW	342k	5.80	View chart
Rapt Therapeutics Call Call Option	0.7	$1.8M	NEW	200k	8.98	View chart
Marinus Pharmaceuticals Com New (MRNS)	0.6	$1.6M	+41%	177k	9.04	View chart
Biovie Cl A New (BIVI)	0.6	$1.6M	NEW	3.0M	0.53	View chart
Tourmaline Bio (TRML)	0.6	$1.5M	NEW	65k	22.90	View chart
Female Health (VERU)	0.6	$1.5M	NEW	2.1M	0.70	View chart
Geron Corp Call Call Option	0.5	$1.3M	NEW	400k	3.30	View chart
Karyopharm Therapeutics (KPTI)	0.4	$1.1M		740k	1.51	View chart
Fat Brands *w Exp 07/16/202 (FATBW)	0.4	$974k		200k	4.87	View chart
Spruce Biosciences (SPRB)	0.4	$904k	NEW	1.2M	0.79	View chart
IsoRay (CATX)	0.3	$637k	NEW	536k	1.19	View chart
Evoke Pharma Com New (EVOK)	0.2	$442k	NEW	725k	0.61	View chart
Perfect Moment Com Shs	0.1	$330k	NEW	92k	3.58	View chart
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW)	0.1	$219k	NEW	732k	0.30	View chart
Nexgel *w Exp 12/01/202 (NXGLW)	0.1	$162k		225k	0.72	View chart
Mobilicom Spon Ads (MOB)	0.1	$161k	NEW	135k	1.19	View chart
Gri Bio Com New	0.1	$143k	NEW	188k	0.76	View chart
Wearable Devices *w Exp 09/14/202 (WLDSW)	0.0	$110k		1.4M	0.08	View chart
Azitra (AZTR)	0.0	$101k	NEW	493k	0.21	View chart
Nocturne Acquisition Corp Right 12/26/2025 (MBTCR)	0.0	$82k		500k	0.16	View chart
Quoin Pharmaceuticals Sponsored Ads (QNRX)	0.0	$63k	NEW	66k	0.95	View chart
Mobix Labs *w Exp 99/99/999 (MOBXW)	0.0	$32k	NEW	150k	0.21	View chart
Digital Health Acquisition C *w Exp 99/99/999 (DHACW)	0.0	$19k		150k	0.13	View chart
Onfolio Holdings *w Exp 01/02/202 (ONFOW)	0.0	$8.1k		200k	0.04	View chart
Nls Pharmaceutics *w Exp 02/02/202 (NLSPW)	0.0	$6.9k		200k	0.03	View chart
Conduit Pharmaceuticals *w Exp 09/22/202 (CDTTW)	0.0	$6.0k		100k	0.06	View chart
Cingulate *w Exp 12/10/202 (CINGW)	0.0	$5.7k		270k	0.02	View chart
Bitcoin Depot *w Exp 06/30/202 (BTMWW)	0.0	$4.7k		50k	0.09	View chart
Nexalin Technology *w Exp 99/99/999 (NXLIW)	0.0	$4.4k		105k	0.04	View chart
Western Acqstn Ventures Corp *w Exp 99/99/999 (WAVSW)	0.0	$4.3k		100k	0.04	View chart
Jeffs Brands *w Exp 99/99/999 (JFBRW)	0.0	$4.0k	-85%	69k	0.06	View chart
Surrozen *w Exp 08/01/203 (SRZNW)	0.0	$3.4k		82k	0.04	View chart
Cea Industries *w Exp 02/11/202 (CEADW)	0.0	$3.3k		250k	0.01	View chart
Prosomnus *w Exp 04/20/202 (OSAAW)	0.0	$3.0k		150k	0.02	View chart
Coliseum Acquisition Corp *w Exp 08/22/202 (MITAW)	0.0	$1.9k		28k	0.07	View chart
Selina Hospitality *w Exp 10/27/202 (SLNAW)	0.0	$710.073000		101k	0.01	View chart
Tc Biopharm Holdings *w Exp 02/10/202 (TCBPW)	0.0	$376.460000		19k	0.02	View chart
Bruush Oral Care *w Exp 08/03/202 (BRSHW)	0.0	$109.614800		14k	0.01	View chart
Relativity Acquisition Corp *w Exp 12/15/202 (RACYW)	0.0	$0		100k	0.00	View chart

Past Filings by Altium Capital Management

SEC 13F filings are viewable for Altium Capital Management going back to 2020

Altium Capital Management 2024 Q1 filed May 15, 2024
Altium Capital Management 2023 Q3 filed Nov. 14, 2023
Altium Capital Management 2023 Q2 filed Aug. 14, 2023
Altium Capital Management 2023 Q1 filed May 15, 2023
Altium Capital Management 2022 Q4 filed Feb. 14, 2023
Altium Capital Management 2022 Q3 filed Nov. 14, 2022
Altium Capital Management 2022 Q2 filed Aug. 15, 2022
Altium Capital Management 2022 Q1 filed May 16, 2022
Altium Capital Management 2021 Q4 filed Feb. 14, 2022
Altium Capital Management 2021 Q3 restated filed Nov. 17, 2021
Altium Capital Management 2021 Q3 filed Nov. 15, 2021
Altium Capital Management 2021 Q2 filed Aug. 13, 2021
Altium Capital Management 2021 Q1 filed May 6, 2021
Altium Capital Management 2020 Q4 restated filed May 5, 2021
Altium Capital Management 2020 Q4 filed Feb. 16, 2021

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z